ALL COMPANIES

Radotinib is a small molecule c-Abl kinase inhibitor. By inhibiting c-Abl kinase, radotinib seeks to protect against neurodegeneration and slow...

Vodobatinib (K-0706) is a small molecule which inhibits c-Abl kinase. Its mechanism is focused on inhibiting c-Abl to mitigate neuronal...

KM-819 is a small molecule functioning as a FAF1 antagonist. FAF1 (Fas-Associated Factor 1) is a protein involved in apoptotic...

Pasinezumab is an antibody that binds to alpha-synuclein, so it will be broken down by the immune system. However, various...

ABL-301 is an antibody designed to inhibit alpha-synuclein pathology, which is a key mechanism involved in neurodegenerative diseases such as...

Emrusolmin (also known as Anle-138b/TEV-56286) is a small molecule inhibitor of aSyn pathology, working to prevent or reduce the accumulation...

Exidavneumab (BAN-0805) is an antibody that acts as an alpha synuclein pathology inhibitor, with the aim of neutralizing toxic alpha-synuclein...

UB-312 is a vaccine that targets alpha synuclein pathology by generating an immune response against pathological forms of alpha-synuclein, promoting...

UCB-7853 is an antibody that works as an alpha synuclein pathology inhibitor, designed to reduce the pathological spread of misfolded...